1st Edition

Emerging Roles of Nanocarrier in Cancer Therapy

    194 Pages 33 Color Illustrations
    by CRC Press

    This book addresses the limitations of existing therapeutic approaches using nanoparticles. Emerging Roles of Nanocarriers in Cancer Therapy will further provide information for the development of successful cancer nanomedicine therapies.


    • Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment.
    • Covers in detail the characteristics of various nanotechnology-based drug delivery systems.
    • Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction.
    • Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research.
    • Highlights smart strategies for improving the clinical impact of cancer nanomedicine.

    The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.

    Chapter 1: Nanomedicine as Cancer Therapeutics: Current Trends and Opportunities

    Chapter 2: Technology Utilizing Nanoparticles in Treating Cancer

    Chapter 3: Targeted Therapy for Cancer with Nanomedicine

    Chapter 4: Effective Nanomedicine for cancer Therapy

    Chapter 5: Enhancing Cancer Immunotherapy using Nanoparticle-Based Smart Carriers

    Chapter 6: Opportunities and Challenges for Anticancer Nanomedicines based on Polymer–Drug Conjugates in Concurrent /combination treatment

    Chapter 7: siRNA Therapeutic Nanocarriers for the Treatment of Cancer

    Chapter 8: Boosting Nano Medicine Efficacy with Hyperbaric Oxygen Therapy

    Chapter 9: Combo Nanomedicine: The Co-delivery of Multimodal Therapies for Effective, Targeted Plus Secure Treatment of Cancer

    Chapter 10: Multipurpose Micellar Nanomedicine for the Treatment of Cancer

    Chapter 11: Cellular Targeting using Nanoparticles for Targeted Cancer Therapy



    Dr Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of Novel formulation development techniques. He has more than 12.5 years of research experience and presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University since past 8 years. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients.

    Arun Kumar Singh completed his B Pharm and M Pharm from Galgotias University India. 

    Prof Sonali Sundram completed B. Pharm & M. Pharm (Pharmacology) from AKTU, Lucknow. She has worked as research scientist in project of ICMR in King George’s Medical University, Lucknow after that she has joined BBDNIIT and currently she is working in Galgotias University, Greater Noida, India. Her PhD (Pharmacy) work was in the area of Neurodegeneration and Nanoformulation. Her area of interest is neurodegeneration, clinical research, artificial intelligence.